INNOCENTI, TOMMASO
 Distribuzione geografica
Continente #
EU - Europa 178
NA - Nord America 146
AS - Asia 87
Totale 411
Nazione #
US - Stati Uniti d'America 145
IT - Italia 48
PL - Polonia 48
IE - Irlanda 36
CN - Cina 26
HK - Hong Kong 23
SE - Svezia 21
SG - Singapore 15
RU - Federazione Russa 13
JO - Giordania 9
KR - Corea 5
FR - Francia 4
GB - Regno Unito 4
VN - Vietnam 4
IN - India 3
ES - Italia 2
ID - Indonesia 2
CA - Canada 1
CH - Svizzera 1
DE - Germania 1
Totale 411
Città #
Warsaw 48
Dublin 36
Ashburn 29
Hong Kong 16
Moscow 11
Singapore 11
Fairfield 10
Beijing 9
Shanghai 9
West Jordan 8
Cambridge 7
Seattle 7
Lawrence 6
Altamura 5
Chandler 5
Florence 5
Houston 5
Seoul 5
Bari 4
Boardman 4
Bologna 4
Dong Ket 4
Kent 4
New York 4
Woodbridge 4
Boston 3
Buffalo 3
London 3
Prato 3
Princeton 3
Rome 3
Viareggio 3
Barcelona 2
Cagliari 2
Castelli Calepio 2
Cerro al Volturno 2
Medford 2
Montepulciano 2
Paris 2
Pune 2
Romainville 2
San Lazzaro di Savena 2
Wilmington 2
Chennai 1
Corciano 1
Falls Church 1
Genoa 1
Hillsboro 1
Los Angeles 1
Pasadena 1
Pisa 1
Redwood City 1
Scandicci 1
Stirling 1
Toronto 1
Totale 315
Nome #
Stevens-Johnson Syndrome and Herpes Simplex Type 1 Infection during Adalimumab Therapy for Crohn's Disease 92
Increased Risk of Liver Cirrhosis during Azathioprine Therapy for Crohn's Disease 78
Non-small-bowel lesions identification by capsule endoscopy: A single centre retrospective study 49
Practical insights into chronic management of hepatic Wilson's disease 33
Pregnancy outcomes in inflammatory bowel disease: Data from a large cohort survey 32
Understanding fatigue in primary biliary cholangitis: From pathophysiology to treatment perspectives 31
Higher volume growth rate is associated with development of worrisome features in patients with branch duct-intraductal papillary mucinous neoplasms 28
Infliximab is more effective than cyclosporine as a rescue therapy for acute severe ulcerative colitis: a retrospective single-center study 28
Infectious risk of vedolizumab compared with other biological agents in the treatment of inflammatory bowel disease 25
RUVBL1 correlates with chaperones expression in HCC and its activity is required for HSF1-mediated stress response 19
T.03.4 SPHINGOSINES, COUP-TFII AND PANCREATIC CANCER 9
Totale 424
Categoria #
all - tutte 2.420
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.420


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209 0 0 0 0 0 0 0 0 0 0 9 0
2020/202185 5 10 2 19 4 8 4 6 8 11 3 5
2021/202222 2 1 0 0 1 1 1 1 1 4 3 7
2022/2023127 5 13 5 1 11 27 21 8 20 4 8 4
2023/2024162 1 11 11 6 4 17 13 35 8 32 17 7
2024/202519 19 0 0 0 0 0 0 0 0 0 0 0
Totale 424